Forge Biologics

About

Forge Biologics is a gene therapy development engine, enabling access to life changing gene therapy programs.

Grove City,Ohio,United States
51 - 100
https://www.forgebiologics.com

Highlights

Details

Last Funding Type: Series C
Last Funding Money Raised: $90M
Industries: Biotechnology,Medical,Therapeutics
Founded date: Jan 1, 2020
Number Of Employee: 51 - 100
Operating Status: Active
Legal Name: Forge Biologics Holdings, LLC

Forge Biologics is a gene therapy development engine, focused on enabling access to life-changing gene therapies and helping bring them from an idea into reality. The company partners with innovators in the gene therapy community: scientists, physicians, biotech/pharma companies, and patient groups.

It was founded in 2020 and headquartered in Grove City, Ohio.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

5

$330M

Forge Biologics has raised a total of $330M in funding over 2 rounds. Their latest funding was raised on Sep 12, 2022 from a Series C round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Sep 12, 2022	Series C	$90M	2	Aisling Capital Drive Capital	—	Detail
Jan 10, 2022	Debt Financing	$80M	1	MidCap Financial	—	Detail
Jan 10, 2022	Grant	—	1	State of Ohio	—	Detail
Apr 29, 2021	Series B	$120M	6	RA Capital Management	—	Detail
Jul 21, 2020	Series A	$40M	2	Perceptive Advisors	—	Detail

Investors

Number of Lead Investors

Number of Investors

6

9

Forge Biologics is funded by 9 investors. Aisling Capital and Drive Capital are the most recent investors.

Investor Name	Lead Investor	Funding Round
Aisling Capital	Yes	Series C
Drive Capital	Yes	Series C
MidCap Financial	Yes	Debt Financing
State of Ohio	Yes	Grant
RA Capital Management	Yes	Series B
Marshall Wace	—	Series B
Octagon Capital Advisors	—	Series B
Perceptive Advisors	—	Series B
Surveyor Capital	—	Series B